Comparison of CL Wear Between Two Allergy Drops

• Status: Withdrawn
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparison of two allergy drops for enhancing comfort and performance of contact lens wear

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hom, Milton M., OD, FAAO
• Collaborator: Merck Sharp & Dohme Corp.
• Treatments: Epinastine; Olopatadine Hydrochloride

Criteria

Inclusion Criteria:

• Males or females > 18 years old

• Mild to moderate dry eye symptoms

• Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

• Current use of topical cyclosporine

• Known contraindications to any study medication or ingredients

• Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)

• Ocular surgery within the past 3 months